Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCCER-P: Secondary Cytoreductive Surgery in Relapsed Ovarian Cancer
NCT05704621Phase 2Recruiting
- Sponsor
- Korea University Guro Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in ovarian cancer, fallopian tube cancer (PFTC) and primary peritoneal cancer (PPC) (2 arms), sponsored by Korea University Guro Hospital. Primary endpoint: Progression-Free Survival at 2 years. Started Dec 2023; status: recruiting.
02
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT05704621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05704621.